2QKB image
Entry Detail
PDB ID:
2QKB
Title:
Human RNase H catalytic domain mutant D210N in complex with 20-mer RNA/DNA hybrid
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2007-07-10
Release Date:
2007-11-13
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.25
R-Value Work:
0.20
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Ribonuclease H1
Mutations:D210N
Chain IDs:C (auth: A), D (auth: B)
Chain Length:154
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE C MET SELENOMETHIONINE
Primary Citation
Structure of Human RNase H1 Complexed with an RNA/DNA Hybrid: Insight into HIV Reverse Transcription
Mol.Cell 28 264 276 (2007)
PMID: 17964265 DOI: 10.1016/j.molcel.2007.08.015

Abstact

We report here crystal structures of human RNase H1 complexed with an RNA/DNA substrate. Unlike B. halodurans RNase H1, human RNase H1 has a basic protrusion, which forms a DNA-binding channel and together with the conserved phosphate-binding pocket confers specificity for the B form and 2'-deoxy DNA. The RNA strand is recognized by four consecutive 2'-OH groups and cleaved by a two-metal ion mechanism. Although RNase H1 is overall positively charged, the substrate interface is neutral to acidic in character, which likely contributes to the catalytic specificity. Positions of the scissile phosphate and two catalytic metal ions are interdependent and highly coupled. Modeling of HIV reverse transcriptase (RT) with RNA/DNA in its RNase H active site suggests that the substrate cannot simultaneously occupy the polymerase active site and must undergo a conformational change to toggle between the two catalytic centers. The region that accommodates this conformational change offers a target to develop HIV-specific inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures